Skip to main content

Articles

Page 129 of 143

  1. c-Met is a receptor tyrosine kinase (RTK) that is over-expressed in a variety of cancers and involved in cell growth, invasion, metastasis and angiogenesis. In this study, we investigated the role of c-Met in ...

    Authors: Jinxuan Hou, Jixin Dong, Lijun Sun, Liying Geng, Jing Wang, Jialin Zheng, Yan Li, Julia Bridge, Steven H Hinrichs and Shi-Jian Ding
    Citation: Journal of Translational Medicine 2011 9:64
  2. Adoptive cell therapy (ACT) has emerged as an effective treatment for patients with metastatic melanoma. However, there are several logistical and safety concerns associated with large-scale ex vivo expansion of ...

    Authors: Thomas Zuliani, Julien David, Sylvain Bercegeay, Marie-Christine Pandolfino, Isabelle Rodde-Astier, Amir Khammari, Cécile Coissac, Bruno Delorme, Soraya Saïagh and Brigitte Dréno
    Citation: Journal of Translational Medicine 2011 9:63
  3. Berberine (BBR) is a drug with multiple effects on cellular energy metabolism. The present study explored answers to the question of which CYP450 (Cytochrome P450) isoenzymes execute the phase-I transformation...

    Authors: Yi Li, Gang Ren, Yan-Xiang Wang, Wei-Jia Kong, Peng Yang, Yue-Ming Wang, Ying-Hong Li, Hong Yi, Zhuo-Rong Li, Dan-Qing Song and Jian-Dong Jiang
    Citation: Journal of Translational Medicine 2011 9:62
  4. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is an early characteristic of multiple organ dysfunction, responsible for high mortality and poor prognosis in patients. The present study...

    Authors: Meitang Wang, Tao Liu, Dian Wang, Yonghua Zheng, Xiangdong Wang and Jian He
    Citation: Journal of Translational Medicine 2011 9:61
  5. Led by key opinion leaders in the field, the 25th Annual Meeting of the International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) provided a...

    Authors: James M Balwit, Pawel Kalinski, Vernon K Sondak, Pierre G Coulie, Elizabeth M Jaffee, Thomas F Gajewski and Francesco M Marincola
    Citation: Journal of Translational Medicine 2011 9:60
  6. Implantation and growth of metastatic cancer cells at distant organs is promoted by inflammation-dependent mechanisms. A hepatic melanoma metastasis model where a majority of metastases are generated via inter...

    Authors: Clarisa Salado, Elvira Olaso, Natalia Gallot, Maria Valcarcel, Eider Egilegor, Lorea Mendoza and Fernando Vidal-Vanaclocha
    Citation: Journal of Translational Medicine 2011 9:59
  7. Neuroserpin has shown neuroprotective effects in animal models of cerebral ischemia and has been associated with functional outcome after ischemic stroke. Our aim was to study whether neuroserpin serum levels ...

    Authors: Raquel Rodríguez-González, Tomás Sobrino, Manuel Rodríguez-Yáñez, Mónica Millán, David Brea, Elena Miranda, Octavio Moldes, Juan Pérez, David A Lomas, Rogelio Leira, Antoni Dávalos and José Castillo
    Citation: Journal of Translational Medicine 2011 9:58
  8. Pharmaceutical industry consolidation and overall research downsizing threatens the ability of companies to benefit from their previous investments in translational research as key leaders with the most knowle...

    Authors: Bruce H Littman and Francesco M Marincola
    Citation: Journal of Translational Medicine 2011 9:56
  9. Hepatocyte growth factor (HGF) stimulates hepatocyte proliferation, and also acts as an anti-apoptotic factor. Therefore, HGF is a potential therapeutic agent for treatment of fatal liver diseases. We performe...

    Authors: Akio Ido, Akihiro Moriuchi, Masatsugu Numata, Toshinori Murayama, Satoshi Teramukai, Hiroyuki Marusawa, Naohisa Yamaji, Hitoshi Setoyama, Il-Deok Kim, Tsutomu Chiba, Shuji Higuchi, Masayuki Yokode, Masanori Fukushima, Akira Shimizu and Hirohito Tsubouchi
    Citation: Journal of Translational Medicine 2011 9:55
  10. In 2009 the NIH publicly announced five strategic goals for the institutes that included the critical need to translate research discoveries into public benefit at an accelerated pace, with a commitment to fin...

    Authors: Michael R Emmert-Buck
    Citation: Journal of Translational Medicine 2011 9:54
  11. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has been considered as a promising treatment modality for gastric cancer with peritoneal carcinomatosis (PC). However, there h...

    Authors: Li Tang, Lie-Jun Mei, Xiao-Jun Yang, Chao-Qun Huang, Yun-Feng Zhou, Yutaka Yonemura and Yan Li
    Citation: Journal of Translational Medicine 2011 9:53
  12. High-dose Interferon (HDI) therapy produces a clinical response and achieves relapse-free survival in 20-33% of patients with operable high risk or metastatic melanoma. However, patients may develop significan...

    Authors: Diana L Simons, Gerald Lee, John M Kirkwood and Peter P Lee
    Citation: Journal of Translational Medicine 2011 9:52
  13. Reactive oxygen species are important mediators exerting toxic effects on various organs during ischemia-reperfusion (IR) injury. We hypothesized that adipose-derived mesenchymal stem cells (ADMSCs) protect th...

    Authors: Yen-Ta Chen, Cheuk-Kwan Sun, Yu-Chun Lin, Li-Teh Chang, Yung-Lung Chen, Tzu-Hsien Tsai, Sheng-Ying Chung, Sarah Chua, Ying-Hsien Kao, Chia-Hung Yen, Pei-Lin Shao, Kuan-Cheng Chang, Steve Leu and Hon-Kan Yip
    Citation: Journal of Translational Medicine 2011 9:51
  14. Emerging evidence suggests that cancer stem cells account for the initiation and progression of cancer. While many types of cancer stem cells with specific markers have been isolated and identified, a variety ...

    Authors: Hai-Guang Liu, Chong Chen, Han Yang, Yi-Fei Pan and Xiao-Hua Zhang
    Citation: Journal of Translational Medicine 2011 9:50
  15. Transglutamiase-4 (TGase-4), also known as prostate transglutaminase, belongs to the TGase family and is uniquely expressed in the prostate gland. The functions of this interesting protein are not clearly defi...

    Authors: Richard J Ablin, Howard G Kynaston, Malcolm D Mason and Wen G Jiang
    Citation: Journal of Translational Medicine 2011 9:49
  16. siRNA technology is a promising tool for gene therapy of vascular disease. Due to the multitude of reagents and cell types, RNAi experiment optimization can be time-consuming. In this study adherent cell cytom...

    Authors: Christoph S Nabzdyk, Maggie Chun, Leena Pradhan and Frank W LoGerfo
    Citation: Journal of Translational Medicine 2011 9:48
  17. Exosomes or secreted bi-lipid vesicles from human ESC-derived mesenchymal stem cells (hESC-MSCs) have been shown to reduce myocardial ischemia/reperfusion injury in animal models. However, as hESC-MSCs are not...

    Authors: Tian Sheng Chen, Fatih Arslan, Yijun Yin, Soon Sim Tan, Ruenn Chai Lai, Andre Boon Hwa Choo, Jayanthi Padmanabhan, Chuen Neng Lee, Dominique PV de Kleijn and Sai Kiang Lim
    Citation: Journal of Translational Medicine 2011 9:47
  18. Polyethyleneimine (PEI), which can interact with negatively charged DNA through electrostatic interaction to form nanocomplexes, has been widely attempted to use as a gene delivery system. However, PEI has som...

    Authors: Zhizhong Xu, Guobo Shen, Xiangying Xia, Xinyu Zhao, Peng Zhang, Huanhuan Wu, Qingfa Guo, Zhiyong Qian, Yuquan Wei and Shufang Liang
    Citation: Journal of Translational Medicine 2011 9:46
  19. We previously demonstrated that the plant-derived agent α-bisabolol enters cells via lipid rafts, binds to the pro-apoptotic Bcl-2 family protein BID, and may induce apoptosis. Here we studied the activity of α-b...

    Authors: Elisabetta Cavalieri, Antonella Rigo, Massimiliano Bonifacio, Alessandra Carcereri de Prati, Emanuele Guardalben, Christian Bergamini, Romana Fato, Giovanni Pizzolo, Hisanori Suzuki and Fabrizio Vinante
    Citation: Journal of Translational Medicine 2011 9:45
  20. The differentiation of CD8+ T lymphocytes following priming of naïve cells is central in the establishment of the adaptive immune response. Yet, the molecular events underlying this process are not fully understo...

    Authors: Bruno Salaun, Takuya Yamamoto, Bassam Badran, Yasuko Tsunetsugu-Yokota, Antoine Roux, Lukas Baitsch, Redouane Rouas, Hussein Fayyad-Kazan, Petra Baumgaertner, Estelle Devevre, Anirudh Ramesh, Marion Braun, Daniel Speiser, Brigitte Autran, Philippe Martiat, Victor Appay…
    Citation: Journal of Translational Medicine 2011 9:44
  21. The lack of sufficient specificity and sensitivity among conventional cancer biomarkers, such as prostate specific antigen (PSA) for prostate cancer has been widely recognized after several decades of clinical...

    Authors: Chong Xie, Hyun J Kim, Jonathan G Haw, Anusha Kalbasi, Brian K Gardner, Gang Li, Jianyu Rao, David Chia, Monty Liong, Rubio R Punzalan, Leonard S Marks, Allan J Pantuck, Alexandre de la Taille, Guomin Wang, Hideki Mukouyama and Gang Zeng
    Citation: Journal of Translational Medicine 2011 9:43
  22. Increased synthesis of neopterin and degradation of tryptophan to kynurenine, measured as kynurenine/tryptophan ratio (kyn/trp ratio), are considered in vitro markers of interferon beta-1a (IFNβ-1a) activity. The...

    Authors: Valentina Durastanti, Alessandra Lugaresi, Placido Bramanti, Mariapia Amato, Paolo Bellantonio, Giovanna De Luca, Orietta Picconi, Roberta Fantozzi, Laura Locatelli, Annalisa Solda', Edoardo Sessa, Rocco Totaro, Silvia Marino, Valentina Zipoli, Marino Zorzon and Enrico Millefiorini
    Citation: Journal of Translational Medicine 2011 9:42
  23. Granulysin is an antimicrobial and proinflammatory protein with several isoforms. While the 9 kDa isoform is a well described cytolytic molecule with pro-inflammatory activity, the functions of the 15 kDa isof...

    Authors: Luciano Castiello, David F Stroncek, Michael W Finn, Ena Wang, Francesco M Marincola, Carol Clayberger, Alan M Krensky and Marianna Sabatino
    Citation: Journal of Translational Medicine 2011 9:41
  24. Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commis...

    Authors: Sarah Brinckmann, Kelly da Costa, Marit J van Gils, David Hallengärd, Katja Klein, Luisa Madeira, Lara Mainetti, Paolo Palma, Katharina Raue, David Reinhart, Marc Reudelsterz, Nicolas Ruffin, Janna Seifried, Katrein Schäfer, Enas Sheik-Khalil, Annette Sköld…
    Citation: Journal of Translational Medicine 2011 9:40
  25. Gene therapy is a promising therapeutic approach for cancer. Targeted expression of desired therapeutic proteins within the tumor is the best approach to reduce toxicity and improve survival. This study is to ...

    Authors: Yu Xu, Jinxuan Hou, Zhengchun Liu, Haijun Yu, Wenjie Sun, Jie Xiong, Zhengkai Liao, Fuxiang Zhou, Conghua Xie and Yunfeng Zhou
    Citation: Journal of Translational Medicine 2011 9:39
  26. The aim of the present study was to analyze the expression of Cyclin-dependent kinase 4 (CDK4) in lung cancer and its correlation with clinicopathologic features. Furthermore, the involvement of CDK4-mediated cel...

    Authors: Aibing Wu, Bin Wu, Jinsong Guo, Weiren Luo, Dong Wu, Huiling Yang, Yan Zhen, Xiaoli Yu, Hao Wang, Ying Zhou, Zhen Liu, Weiyi Fang and Zhixiong Yang
    Citation: Journal of Translational Medicine 2011 9:38
  27. Interleukin-13 Receptor α2 (IL-13Rα2) is a tumor-associated antigen and target for cancer therapy. Since IL-13Rα2 is heterogeneously overexpressed in a variety of human cancers, it would be highly desirable to...

    Authors: Toshio Fujisawa, Bharat H Joshi and Raj K Puri
    Citation: Journal of Translational Medicine 2011 9:37
  28. Oncolytic viruses show promise for treating cancer. However, to assess therapeutic efficacy and potential toxicity, a noninvasive imaging modality is needed. This study aimed to determine if insertion of the h...

    Authors: Dana Haddad, Nanhai G Chen, Qian Zhang, Chun-Hao Chen, Yong A Yu, Lorena Gonzalez, Susanne G Carpenter, Joshua Carson, Joyce Au, Arjun Mittra, Mithat Gonen, Pat B Zanzonico, Yuman Fong and Aladar A Szalay
    Citation: Journal of Translational Medicine 2011 9:36
  29. Emerging data from pre-clinical and clinical studies suggest that HER-2/neu-specific T cell responses could induce HER-2/neu antigen loss in the tumor cells. These data suggest that patients with HER-2/neu neg...

    Authors: Maciej Kmieciak, Kyle K Payne, Michael O Idowu, Margaret M Grimes, Laura Graham, Maria-Libera Ascierto, Ena Wang, Xiang-Yang Wang, Harry D Bear and Masoud H Manjili
    Citation: Journal of Translational Medicine 2011 9:35
  30. Many peptide-based cancer vaccines have been tested in clinical trials with a limited success, mostly due to difficulties associated with peptide stability and delivery, resulting in inefficient antigen presen...

    Authors: Wenxue Ma, Trevor Smith, Vladimir Bogin, Yu Zhang, Cengiz Ozkan, Mihri Ozkan, Melanie Hayden, Stephanie Schroter, Ewa Carrier, Davorka Messmer, Vipin Kumar and Boris Minev
    Citation: Journal of Translational Medicine 2011 9:34
  31. Infiltration of colorectal carcinomas (CRC) with T-cells has been associated with good prognosis. There are some indications that chemokines could be involved in T-cell infiltration of tumors. Selective modula...

    Authors: Klara Berencsi, Pyapalli Rani, Tianqian Zhang, Laura Gross, Michael Mastrangelo, Neal J Meropol, Dorothee Herlyn and Rajasekharan Somasundaram
    Citation: Journal of Translational Medicine 2011 9:33
  32. Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical practice. In fact, new therapeutic approaches are eme...

    Authors: Paolo A Ascierto, Eleonora De Maio, Stefano Bertuzzi, Giuseppe Palmieri, Ruth Halaban, Mary Hendrix, Mohamed Kashani-sabet, Soldano Ferrone, Ena Wang, Alistair Cochran, Licia Rivoltini, Peter P Lee, Bernard A Fox, John M Kirkwood, Claudio Dansky Ullmann, Frederic F Lehmann…
    Citation: Journal of Translational Medicine 2011 9:32
  33. This study was to evaluate the effect of excision repair cross-complementation group 1(ERCC1) expression on response to cisplatin-based induction chemotherapy (IC) followed by concurrent chemoradiation (CCRT) ...

    Authors: Tai-Jan Chiu, Chang-Han Chen, Chih-Yen Chien, Shau-Hsuan Li, Hsin-Ting Tsai and Yi-Ju Chen
    Citation: Journal of Translational Medicine 2011 9:31
  34. Esophageal squamous cell carcinoma (ESCC) is often diagnosed at later stages until they are incurable. MicroRNA (miR) is a small, non-coding RNA that negatively regulates gene expression mainly via translation...

    Authors: Kayoko Matsushima, Hajime Isomoto, Naoyuki Yamaguchi, Naoki Inoue, Haruhisa Machida, Toshiyuki Nakayama, Tomayoshi Hayashi, Masaki Kunizaki, Shigekazu Hidaka, Takeshi Nagayasu, Masahiro Nakashima, Kenta Ujifuku, Norisato Mitsutake, Akira Ohtsuru, Shunichi Yamashita, Manav Korpal…
    Citation: Journal of Translational Medicine 2011 9:30
  35. Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of damaged tissues for which there are currently no or limited therapeutic options. The potential of stem cell therapies ha...

    Authors: Carla A Herberts, Marcel SG Kwa and Harm PH Hermsen
    Citation: Journal of Translational Medicine 2011 9:29
  36. Several cytokines are associated with the development and/or progression of chronic heart failure (CHF). Our aim was to look more closely at the cytokine networks involved in CHF, and to assess whether disease...

    Authors: Claudia Cappuzzello, Luca Di Vito, Roberta Melchionna, Guido Melillo, Lorena Silvestri, Eleonora Cesareo, Filippo Crea, Giovanna Liuzzo, Antonio Facchiano, Maurizio C Capogrossi and Monica Napolitano
    Citation: Journal of Translational Medicine 2011 9:28
  37. Glutamate excitotoxicity is thought to be involved in the pathogenesis of neurodegenerative disease. One potential source of glutamate is N-acetyl-aspartyl-glutamate (NAAG) which is hydrolyzed to glutamate and...

    Authors: Camilo Rojas, Marigo Stathis, Michael Polydefkis, Michelle A Rudek, Ming Zhao, Gigi J Ebenezer and Barbara S Slusher
    Citation: Journal of Translational Medicine 2011 9:27
  38. Clinical trials of immunologic therapies provide opportunities to study the cellular and molecular effects of those therapies and may permit identification of biomarkers of response. When the trials are perfor...

    Authors: Walter C Olson, Mark E Smolkin, Erin M Farris, Robyn J Fink, Andrea R Czarkowski, Jonathan H Fink, Kimberly A Chianese-Bullock and Craig L Slingluff Jr
    Citation: Journal of Translational Medicine 2011 9:26
  39. The history of ascorbic acid (AA) and cancer has been marked with controversy. Clinical studies evaluating AA in cancer outcome continue to the present day. However, the wealth of data suggesting that AA may b...

    Authors: Thomas E Ichim, Boris Minev, Todd Braciak, Brandon Luna, Ron Hunninghake, Nina A Mikirova, James A Jackson, Michael J Gonzalez, Jorge R Miranda-Massari, Doru T Alexandrescu, Constantin A Dasanu, Vladimir Bogin, Janis Ancans, R Brian Stevens, Boris Markosian, James Koropatnick…
    Citation: Journal of Translational Medicine 2011 9:25
  40. After publication of our article [1], we realized the need for posting a correction note in order to prevent i) overinterpretation of some results by the readers and ii) concerns about potentially unintended misg...

    Authors: Michaela Muth, Kais Hussein, Christoph Jacobi, Hans Kreipe and Oliver Bock
    Citation: Journal of Translational Medicine 2011 9:24

    The original article was published in Journal of Translational Medicine 2010 8:33

  41. Septic shock is the most feared complication of chemotherapy-induced febrile neutropenia. So far, there are no robust biomarkers that can stratify patients to the risk of sepsis complications. The VEGF-A axis ...

    Authors: Brunna E Alves, Silmara AL Montalvao, Francisco JP Aranha, Irene Lorand-Metze, Carmino A De Souza, Joyce M Annichino-Bizzacchi and Erich V De Paula
    Citation: Journal of Translational Medicine 2011 9:23
  42. Interactions between CXCR4 and its ligand CXCL12 have been shown to be involved in cancer progression in colorectal cancer (CRC). We performed a comparative CXCL12/CXCR4 expression analysis and assessed the ef...

    Authors: Claudia Rubie, Vilma O Frick, Pirus Ghadjar, Mathias Wagner, Christoph Justinger, Sabrina K Faust, Benjamin Vicinus, Stefan Gräber, Otto Kollmar and Martin K Schilling
    Citation: Journal of Translational Medicine 2011 9:22
  43. Alpha-1 antitrypsin (AAT) is a multi-functional protein that has anti-inflammatory and tissue protective properties. We previously reported that human AAT (hAAT) gene therapy prevented autoimmune diabetes in n...

    Authors: Christian Grimstein, Young-Kook Choi, Clive H Wasserfall, Minoru Satoh, Mark A Atkinson, Mark L Brantly, Martha Campbell-Thompson and Sihong Song
    Citation: Journal of Translational Medicine 2011 9:21
  44. Laser surgery lacks haptic feedback, which is accompanied by the risk of iatrogenic nerve damage. It was the aim of this study to investigate diffuse reflectance spectroscopy for tissue differentiation as the ...

    Authors: Florian Stelzle, Azhar Zam, Werner Adler, Katja Tangermann-Gerk, Alexandre Douplik, Emeka Nkenke and Michael Schmidt
    Citation: Journal of Translational Medicine 2011 9:20
  45. Metabolic reprogramming resulting in enhanced glycolysis is a phenotypic trait of cancer cells, which is imposed by the tumor microenvironment and is linked to the down-regulation of the catalytic subunit of t...

    Authors: María Sánchez-Aragó and José M Cuezva
    Citation: Journal of Translational Medicine 2011 9:19
  46. The Society for Immunotherapy of Cancer, SITC (formerly the International Society for Biological Therapy of Cancer, iSBTc), aims to improve cancer patient outcomes by advancing the science, development and app...

    Authors: James M Balwit, Patrick Hwu, Walter J Urba and Francesco M Marincola
    Citation: Journal of Translational Medicine 2011 9:18
  47. Recent advances in medical technology and key discoveries in biomedical research have the potential to improve human health in an unprecedented fashion. As a result, many of the Arab Gulf countries, particular...

    Authors: Lotfi Chouchane, Ravinder Mamtani, Mohammed H Al-Thani, Al-Anoud M Al-Thani, Marco Ameduri and Javaid I Sheikh
    Citation: Journal of Translational Medicine 2011 9:16
  48. Since the discovery of CCR5 as a coreceptor for HIV entry, there has been interest in blockade of the receptor for treatment and prevention of HIV infection. Although several CCR5 antagonists have been evaluat...

    Authors: Bruce L Gilliam, David J Riedel and Robert R Redfield
    Citation: Journal of Translational Medicine 2011 9(Suppl 1):S9

    This article is part of a Supplement: Volume 9 Supplement 1

Annual Journal Metrics